I

InfuSystem Holdings Inc
AMEX:INFU

Watchlist Manager
InfuSystem Holdings Inc
AMEX:INFU
Watchlist
Price: 8.86 USD -1.01% Market Closed
Market Cap: 188.1m USD
Have any thoughts about
InfuSystem Holdings Inc?
Write Note

InfuSystem Holdings Inc
Other Equity

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

InfuSystem Holdings Inc
Other Equity Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Other Equity CAGR 3Y CAGR 5Y CAGR 10Y
I
InfuSystem Holdings Inc
AMEX:INFU
Other Equity
$836k
CAGR 3-Years
129%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
DaVita Inc
NYSE:DVA
Other Equity
-$162.3m
CAGR 3-Years
-11%
CAGR 5-Years
-16%
CAGR 10-Years
-27%
Quest Diagnostics Inc
NYSE:DGX
Other Equity
-$15m
CAGR 3-Years
-5%
CAGR 5-Years
23%
CAGR 10-Years
0%
CVS Health Corp
NYSE:CVS
Other Equity
$94m
CAGR 3-Years
-18%
CAGR 5-Years
-7%
CAGR 10-Years
N/A
Cigna Corp
NYSE:CI
Other Equity
-$2.2B
CAGR 3-Years
-23%
CAGR 5-Years
-20%
CAGR 10-Years
-8%
Laboratory Corporation of America Holdings
NYSE:LH
Other Equity
-$113.2m
CAGR 3-Years
25%
CAGR 5-Years
26%
CAGR 10-Years
N/A
No Stocks Found

InfuSystem Holdings Inc
Glance View

Market Cap
188.1m USD
Industry
Health Care

InfuSystem Holdings, Inc. engages in the provision of healthcare services. The company is headquartered in Rochester Hills, Michigan and currently employs 420 full-time employees. The company went IPO on 2006-06-15. The Company’s segments include Integrated Therapy Services (ITS) and Durable Medical Equipment Services (DME Services). The Company’s core service within its ITS segment is its Oncology Business. The ITS segment supplies electronic ambulatory infusion pumps and associated disposable supply kits to private oncology clinics, infusion clinics and hospital outpatient oncology clinics to be utilized in the treatment of a variety of cancers, including colorectal cancer and other disease states. Its DME Services segments core service is to sell or rent new and pre-owned pole-mounted and ambulatory infusion pumps and other Durable Medical Equipment; sell treatment-related consumables; and provide biomedical recertification, maintenance and repair services for oncology practices as well as other healthcare site settings.

INFU Intrinsic Value
10.8 USD
Undervaluation 18%
Intrinsic Value
Price
I

See Also

What is InfuSystem Holdings Inc's Other Equity?
Other Equity
836k USD

Based on the financial report for Sep 30, 2024, InfuSystem Holdings Inc's Other Equity amounts to 836k USD.

What is InfuSystem Holdings Inc's Other Equity growth rate?
Other Equity CAGR 3Y
129%

Over the last year, the Other Equity growth was -49%. The average annual Other Equity growth rates for InfuSystem Holdings Inc have been 129% over the past three years .

Back to Top